Zebra Biologics, Inc.
Biotechnology company · Concord, Massachusetts, United States
Zebra Biologics, Inc. is a biotechnology company headquartered in Concord, Massachusetts, United States. Its earliest recorded incorporation is in 2013. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $823,544 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2015.
Zebra Biologics at a glance
What does Zebra Biologics do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $823,544 in total (2019 to 2021). NIH funding came from the National Institute on Deafness and Other Communication Disorders, National Eye Institute, National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $3 million sold (2015).
Frequently asked questions about Zebra Biologics
Where is Zebra Biologics headquartered?
Zebra Biologics, Inc. is headquartered in Concord, Massachusetts, United States.
What does Zebra Biologics do?
Zebra Biologics, Inc. is a biotechnology company.
When was Zebra Biologics founded?
The earliest incorporation on record for Zebra Biologics, Inc. is in 2013, according to public company registers.
Similar companies
- Applied BioMath, LLCConcord, Massachusetts, United States
- Sigray, Inc.Concord, California, United States
- Fairbanks Pharmaceuticals IncConcord, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences